1. Salvage Second Hematopoietic Cell Transplantation in Myeloma
Laura C. Michaelis, Ayman Saad, Xiaobo Zhong, Jennifer Le-Rademacher, Cesar O. Freytes, David I. Marks, Hillard M. Lazarus, Jennifer M. Bird, Leona Holmberg, Rammurti T. Kamble, Shaji Kumar, Michael Lill, Kenneth R. Meehan, Wael Saber, Jeffrey Schriber, Jason Tay, Dan T. Vogl, Baldeep Wirk, Bipin N. Savani, Robert P. Gale, David H. Vesole, Gary J. Schiller, Muneer Abidi, Kenneth C. Anderson, Taiga Nishihori, Matt E. Kalaycio, Julie M. Vose, Jan S. Moreb, William Drobyski, Reinhold Munker, Vivek Roy, Armin Ghobadi, H. Kent Holland, Rajneesh Nath, L. Bik To, Angelo Maiolino, Adetola A. Kassim, Sergio A. Giralt, Heather Landau, Harry C. Schouten, Richard T. Maziarz, Joseph Mikhael, Tamila Kindwall-Keller, Patrick J. Stiff, John Gibson, Sagar Lonial, Amrita Krishnan, Angela Dispenzieri, Parameswaran Hari 
Biology of Blood and Marrow Transplantation 
Volume 19, Issue 5, Pages (May 2013)
DOI: /j.bbmt
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Cumulative incidence of relapse/progression and NRM after salvage AHCT2.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2 Probability of PFS and OS after AHCT2.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

4. Figure 3
Probability of OS after AHCT2 stratified by time to relapse/progression from AHCT1.
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions